Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Plasmopara viticola effector PvRxLR24 (a potential phosphatase) interferes grapevine stomatal immunity by targeting VvOST1.

Created on 07 Sep 2026

Authors

Zhizhuo Xu, Yasheng Xi, Xiukun Yao, Xinyue He, Qifei Gao, Jiang Lu, Peining Fu

Published in

Plant physiology. Sep 07, 2026. Epub Sep 07, 2026.

Abstract

Numerous pathogens invade plants through stomata, and plants, on the other hands, could close the stomata after sensing the pathogens PAMPs. Subsequently, pathogens could overcome this plant immune response with their phytotoxins and effectors. A previous study showed that Plasmopara viticola, a strictly obligate biotrophic oomycete, could inhibit the Vitis vinifera stomatal closure to promote infection. However, the underlying mechanism stimulating the stomata movement is still poorly understood. Here we demonstrate that PvRxLR24, an effector from P. viticola, functions analogously to a phosphatase by directly inhibiting the kinase activity of OPEN STOMATA 1 (OST1), a central regulator of ABA signaling and stomatal closure. This inhibition subsequently abolishes the activation of the slow-type anion channel SLAC1, resulting in a "stomatal lock" open state. Our study demonstrated that OST1 is the direct target of pathogen effectors, shedding light on a new mechanism by which pathogens could manipulate the plant ABA signaling pathways to influence stomatal movement for successful invasion.

PMID:
42703733
Bibliographic data and abstract were imported from PubMed on 07 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement